Header cover image

Investing Ideas
/
Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

10

0 new

Companies which are more than 50% undervalued based on analyst price target.

10 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	4523 Eisai	JP¥4,662.00	0.9%	-39.2%	JP¥1.3t	JP¥7,127.94	PE32.1x	E13.2%	3.4%
	4565 Nxera Pharma	JP¥1,140.00	0.3%	-17.9%	JP¥102.5b	JP¥2,060.00	PS3.5x	E47.3%	n/a
	4599 StemRIM	JP¥354.00	-0.8%	-48.8%	JP¥21.8b	JP¥700.00	PB2.4x	E6.5%	n/a
	7774 Japan Tissue Engineering	JP¥494.00	0%	-1.8%	JP¥20.1b	JP¥1,200.00	PS8.3x	E51.1%	n/a
	4593 Healios K.K	JP¥201.00	3.1%	21.8%	JP¥18.1b	JP¥340.00	PS34.8x	E35.2%	n/a
	4597 Solasia Pharma K.K	JP¥57.00	29.5%	39.0%	JP¥12.4b	JP¥120.00	PS129.3x	E71.3%	n/a
	4579 RaQualia Pharma	JP¥453.00	-2.8%	-42.9%	JP¥9.8b	JP¥1,200.00	PS3.5x	E37.7%	n/a
	4891 TMS	JP¥225.00	9.8%	-5.1%	JP¥9.1b	JP¥760.00	PB3x	n/a	n/a
	4893 Noile-Immune Biotech	JP¥171.00	1.8%	-47.9%	JP¥7.4b	JP¥440.00	PS1057.8x	E-14.9%	n/a
	4584 Kidswell Bio	JP¥121.00	2.5%	-17.7%	JP¥4.9b	JP¥450.00	n/a	E48.1%	n/a

Page 1 of 1